These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2869064)
1. Alprazolam in the treatment of compulsive symptoms. Ketter T; Chun D; Lu F J Clin Psychopharmacol; 1986 Feb; 6(1):59-60. PubMed ID: 2869064 [No Abstract] [Full Text] [Related]
2. Alprazolam as treatment for a case of obsessive-compulsive disorder. Tesar GE; Jenike MA Am J Psychiatry; 1984 May; 141(5):689-90. PubMed ID: 6143507 [TBL] [Abstract][Full Text] [Related]
3. Alprazolam in the treatment of obsessive symptoms. Tollefson G J Clin Psychopharmacol; 1985 Feb; 5(1):39-42. PubMed ID: 3973070 [TBL] [Abstract][Full Text] [Related]
7. Predictors of benzodiazepine use in a transdiagnostic sample of panic disorder, social anxiety disorder, and obsessive-compulsive disorder patients. Laurito LD; Loureiro CP; Dias RV; Vigne P; de Menezes GB; Freire RC; Stangier U; Fontenelle LF Psychiatry Res; 2018 Apr; 262():237-245. PubMed ID: 29475102 [TBL] [Abstract][Full Text] [Related]
8. A double-blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients. Davison K; Farquharson RG; Khan MC; Majid A Br J Clin Pharmacol; 1985; 19 Suppl 1(Suppl 1):37S-43S. PubMed ID: 2859877 [TBL] [Abstract][Full Text] [Related]
9. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder. Rizley R; Kahn RJ; McNair DM; Frankenthaler LM Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609 [No Abstract] [Full Text] [Related]
11. A double blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients. Davison K; Farquharson RG; Khan MC; Majid A Psychopharmacology (Berl); 1983; 80(4):308-10. PubMed ID: 6137856 [TBL] [Abstract][Full Text] [Related]
12. Three more benzodiazepines. Drug Ther Bull; 1983 Aug; 21(16):63-4. PubMed ID: 6137353 [No Abstract] [Full Text] [Related]
13. Alprazolam for endogenous depression. France RD; Krishnan KR Am J Psychiatry; 1983 May; 140(5):640-1. PubMed ID: 6133462 [No Abstract] [Full Text] [Related]
14. Alprazolam in the treatment of neurotic anxiety. Kerry RJ; McDermott CM Pharmatherapeutica; 1983; 3(7):451-5. PubMed ID: 6142462 [TBL] [Abstract][Full Text] [Related]
15. Benzodiazepines for treatment of panic attacks: a new look. Rickels K; Schweizer EE Psychopharmacol Bull; 1986; 22(1):93-9. PubMed ID: 2873621 [No Abstract] [Full Text] [Related]
16. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression. Dawson GW; Jue SG; Brogden RN Drugs; 1984 Feb; 27(2):132-47. PubMed ID: 6141930 [TBL] [Abstract][Full Text] [Related]
17. A double-blind study of alprazolam and lorazepam in the treatment of anxiety. Ruiz AT J Clin Psychiatry; 1983 Feb; 44(2):60-2. PubMed ID: 6131066 [TBL] [Abstract][Full Text] [Related]
18. Alprazolam (Xanax). Med Lett Drugs Ther; 1982 Apr; 24(607):41-2. PubMed ID: 6123071 [No Abstract] [Full Text] [Related]
19. Treatment of negative schizophrenic symptoms with alprazolam: a preliminary open-label study. Csernansky JG; Lombrozo L; Gulevich GD; Hollister LE J Clin Psychopharmacol; 1984 Dec; 4(6):349-52. PubMed ID: 6150950 [TBL] [Abstract][Full Text] [Related]
20. Pretreatment urinary MHPG levels as predictors of antidepressant responses to alprazolam. Mooney JJ; Cole JO; Schatzberg AF; Gerson B; Schildkraut JJ Am J Psychiatry; 1985 Mar; 142(3):366-7. PubMed ID: 2857533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]